Companies / ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc.
Financials · FY2025
Ownership
99.3M shares outstanding · as of May 13, 2026
Ownership
| 10%+ / strategic | 5.05% | 5,013,000 |
| Institutions | 90.14% | 89,515,071 |
| Public float | 4.81% | 4,775,191 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 15
View all →| Insider | % of shares | Shares |
|---|---|---|
Fitzpatrick Alexander AFormerChief Legal Officer | 0.09% | 90,910 |
Chakma JustinChief Business Officer | — | — |
Dorsey BrianFormerChief Operating Officer | — | — |
Karas EricFormerChief Commercial Officer | — | — |
Kolchinsky PeterDirector · 10% owner | — | — |
Lowenthal Richard ECEOPRESIDENT AND CEO · Director · 10% owner | — | — |
RA Capital Healthcare Fund LPFormerDirector · 10% owner | — | — |
RA Capital Management, L.P.FormerDirector · 10% owner | — | — |
RA Capital Nexus Fund II, L.P.FormerDirector | — | — |
Saunders Brent LFormerDirector | — | — |
Institutional holders 200
View all →| Holder | Value | % of shares |
|---|---|---|
| $87.21M | 10.94% | |
| $72.23M | 6.24% | |
| $66.56M | 8.35% | |
| $60.26M | 7.56% | |
| $48.04M | 6.02% | |
| $46.75M | 4.04% | |
| $42.54M | 5.35% | |
| $41.43M | 3.58% | |
| $40.88M | 3.53% | |
| $29.88M | 3.76% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Fitzpatrick Alexander A Executive | Sell | Common Stock | $33.5K | -3K -3.56% | 90,910 0.09% of shares | low |
| Jun 24, 2026 | Thompson Peter A. Director | Grant | Stock Option (right to buy) | — | +30K | 30,000 0.03% of shares | low |
| Jun 24, 2026 | RA Capital Management, L.P. Director | Grant | Stock Option (Right to Buy) | — | +30K | 30,000 0.03% of shares | low |
| Jun 24, 2026 | Saunders Brent L Director | Grant | Stock Option (right to buy) | — | +30K | 30,000 0.03% of shares | low |
| Jun 24, 2026 | Schneider Phillip M Director | Grant | Stock Option (right to buy) | — | +30K | 30,000 0.03% of shares | low |
| Jan 2, 2026 | Scott Kathleen D. Executive | Grant | Stock option (right to buy) | — | +240K | 240,000 0.24% of shares | low |
| Jan 2, 2026 | Tanimoto Sarina Executive | Grant | Stock Option (right to buy) | — | +875K | 875,000 0.88% of shares | low |
| Jan 2, 2026 | Tanimoto Sarina Executive | Grant | Stock option (right to buy) | — | +240K | 240,000 0.24% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Millennium Management LLC | Passive13G/A | — |
| Millennium Management LLC | Passive13G | — |
| BlackRock, Inc. | Passive13G | — |
| Rubric Capital Management LP | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| SPRY | — | 82835W108 |